Arthex Biotech strengthens its leadership team with the appointment of Glenn P. Sblendorio as Chairman to guide the company's strategic expansion and clinical development initiatives.
ARTHEx Biotech announced the appointment of Glenn P. Sblendorio as Chairman, a governance change with limited direct market impact.
Clinical-stage biotechnology firm Arthex Biotech has named industry veteran Glenn P. Sblendorio as its new Chairman. The appointment aims to bolster the company's corporate strategy and business development efforts as it enters its next phase of clinical growth.
Glenn P. Sblendorio, an experienced biopharmaceutical executive, has been appointed as the new Chairman of Arthex Biotech.